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Abstract
Purpose: To evaluate postoperative clinical outcomes, and corneal High Order Aberrations, among 
eyes with hyperopia up to +5 D of spherical equivalent, that have undergone LASIK treatments 
using the SCHWIND AMARIS laser system.
Methods: At six-month follow-up, 100 eyes with preoperative hyperopia or hyperopic astigmatism 
up to +5 D of spherical equivalent were retrospectively analysed. Standard examinations, pre- and 
postoperative wavefront analysis with a corneal-wavefront-analyzer (OPTIKON Scout) were 
performed. Aberration-Free aspheric treatments were planned with Custom Ablation Manager 
software and ablations performed using the SCHWIND AMARIS Á ying-spot excimer laser system 
(both SCHWIND eye-tech-solutions). LASIK flaps were created using a LDV femtosecond laser 
(Ziemer Group) in all cases. Clinical outcomes were evaluated in terms of predictability, refractive 
outcome, safety, and wavefront aberration.
Results: At six month, 90 % of eyes achieved ≥ 20/25 UCVA and 44 % achieved ≥ 20/16 UCVA. 
Seventy-four percent of eyes were within ± 0.25D of spherical equivalent and 89 % within ± 0.50D, 
with 94 % within 0.50D of astigmatism. Mean spherical equivalent was —0.12 ± 0.51D and 
0.50 ± 0.51D for the astigmatism. Fifty-two percent of eyes improved BSCVA vs. only 19 % losing 
lines of BSCVA. Predictability slope for refraction was 1.03 and intercept +0.01 D. On average, 
negative corneal spherical aberrations were signiÀ cantly increased by the treatments, no other 
aberration terms changed from pre- to postoperative values.
Conclusions: LASIK for hyperopia and hyperopic astigmatism with SCHWIND AMARIS yields very 
satisfactory visual outcomes. Preoperative refractions were postoperatively reduced to subclinical 
values with no clinically relevant induction of corneal HOA.
© 2010 Spanish General Council of Optometry. Published by Elsevier España, S.L. All rights reserved.
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The introduction of the excimer laser for refractive surgery 
has opened up the possibility to change the corneal 
curvature to compensate for refractive errors of the eye. In 
the case of small spot hyperopic laser in situ keratomileusis 
(H–LASIK), excimer laser systems produce a steepness of 
the cornea by ablating mainly at the periphery of the 
cornea.
H-LASIK treatments induce aberrations. 1 Studies 2,3 
attempted to determine the changes in corneal asphericity 
after H-LASIK, and found a extreme corneal prolateness, 
indicating large amounts of induced negative spherical 
aberrations. This is predominantly caused by the loss of 
efÀ ciency 4-7 at the periphery and the biomechanics of the 
cornea, and has been described previously by other 
authors. 8,9
The pitfalls of H–LASIK are historically important and 
should be mentioned, as the main problems in decentrations, 
decreases in best corrected visual acuity, very high 
frequency of retreatments, frequent residual refractive 
error, induction of astigmatism and induction of high levels 
of corneal aberrations, specifically, and spherical 
aberration.
PALABRAS CLAVE
Hipermetropía;
Cirugía refractiva;
Láser excimer;
Aberración de frente 
de onda;
Ablación asférica
Resultados clínicos a los seis meses de una corrección de hipermetropía con el láser 
SCHWIND AMARIS Total-Tech
Resumen
Objetivo: Evaluar los resultados clínicos posoperatorios, aberraciones corneales de orden superior, 
entre ojos con una hipermetropía de hasta 5 dioptrías de equivalente esférico, previamente some-
tidos a tratamientos LASIK con el sistema de láser SCHWIND AMARIS.
Métodos: Tras 6 meses de seguimiento, se analizaron de manera retrospectiva 100 ojos con hi-
permetropía o astigmatismo hipermetrópico preoperatorio de hasta 5 dioptrías de equivalente 
esférico. Se llevaron a cabo exploraciones estándar, análisis de frente de onda preoperatorio y 
posoperatorio con un analizador de frente de onda corneal (OPTIKON Scout). Se diseñaron tra-
tamientos asféricos sin aberraciones con el software Custom Ablation Manager y se realizaron 
ablaciones utilizando el sistema de láser excímero de punto Á otante SCHWIND AMARIS (ambas 
tecnologías son de SCHWIND Eye-tech Solutions). En todos los casos, los colgajos de LASIK se 
crearon utilizando un láser de femtosegundo LDV (Ziemer Group). Los resultados clínicos se 
evaluaron a nivel de previsibilidad, resultado de refracción, seguridad y aberración de frente de 
onda.
Resultados: Al cabo de 6 meses, el 90 % de los ojos alcanzaron agudeza visual sin corrección 
(AVSC) > 20/25 AVSC (UCVA) y el 44 % alcanzaron > 20/16 AVSC. El 74 % de los ojos se encontraban 
en +0,25 dioptrías de equivalente esférico y el 89 % en ±0,50 dioptrías, con el 94 % en 0,50 diop-
trías de astigmatismo. La media del equivalente esférico fue de —0,12 ± 0,51 dioptrías y de 
0,50 ± 0,51 dioptrías para astigmatismo. El 52 % de los ojos vieron mejorada la mejor agudeza vi-
sual con gafa (MAVCG) (BSCVA) frente a solamente un 19 % que perdieron líneas de MAVCG. La 
pendiente de previsibilidad de refracción fue de 1,03 y la ordenada en el origen, de +0,01 diop-
trías. Como promedio, la aberración esférica negativa de la córnea fue signiÀ cativamente incre-
mentada por los tratamientos y ningún otro término de aberración cambió entre los valores 
preoperatorios y posoperatorios.
Conclusiones: Utilizar LASIK para la hipermetropía y el astigmatismo hipermetrópico con SCHWIND 
AMARIS produce unos resultados visuales muy satisfactorios. Las refracciones previas a la opera-
ción se vieron reducidas a valores subclínicos después de la operación, sin inducción clínicamente 
relevante de aberraciones de orden superior de la córnea.
© 2010 Spanish General Council of Optometry. Publicado por Elsevier España, S.L. Todos los derechos 
reservados.
Later studies on hyperopic treatments with excimer lasers 
also suggested an increase in negative spherical aberration. 10,11
By comparison of the intended and achieved topographical 
changes after H-LASIK surgery, de Ortueta et al. 12 obtained 
information as to whether the corneal power was changed 
as calculated, thus providing help in optimizing the ablation 
proÀ les (either in terms of nomogram adjustments or more 
sophisticated optimization algorithms like multifocal 
algorithms). Additionally, actual under- or overcorrection 
can be differentiated from under- or overcorrection due to 
wrong intended correction in this way.
A study by O’Brart et al. 13 analyzing hyperopic LASEK using 
a Munnerlyn based classical proÀ le and a 7 mm optical zone 
with a total treated zone of 9 mm demonstrated that the 
induced aberrations were lower than with the Munnerlyn 
proÀ le in LASIK. A recent study by de Ortueta et al., 14 using 
aspheric aberration neutral proÀ les showed that induced 
aberrations are less than in previous publications. This study 
was undertaken to evaluate postoperative clinical outcomes 
and High Order Aberrations (HOA), among eyes with 
hyperopia up to +5 D of spherical equivalent, that underwent 
LASIK treatments using the SCHWIND AMARIS laser system. 15
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Methods
Study Design and Patient Eligibility Criteria
This is a retrospective analysis of consecutively operated 
eyes by a single surgeon (MCA). The first consecutive 
100 eyes (50 patients) with preoperative manifest hyperopia 
or hyperopic astigmatism treated using the AMARIS 
“aberration neutral” (Aberration-FreeTM) aspheric ablation 
proÀ les were retrospectively analysed. In fact, there was no 
nomogram check before commencing the study, and there 
were no eyes excluded because lost to follow-up or because 
they required re-treatments.
This is the À rst series of eyes operated with this particular 
treatment algorithm. Due to its retrospective nature, no 
investigational review board or other regulatory oversight 
was required. The level of statistical signiÀ cance was taken 
as P < .05.
Inclusion criteria for review were preoperative hyperopia 
or hyperopic astigmatism targeted for emmetropia, best 
spectacle corrected visual acuity (BSCVA) ≥ 20/25 
(logMAR ≤ +0.1), < 0.75 mm root mean square (RMS) of the 
HOA of the corneal wave aberration for 6-mm diameter, 
and successful completion of 6-month follow-up. All 
50 patients (100 eyes) fulÀ lled the criteria for being taken 
in the retrospective analysis, and so no one was excluded.
Laser Description
All ablations were non-customised based on “aberration 
neutral” proÀ les and calculated using the ORK-CAM software 
module. Aspheric aberration neutral 16 (Aberration-FreeTM17) 
proÀ les are not based on the Munnerlyn proposed proÀ les, 18 
and go beyond that by adding some aspheric characteristics 
to balance the induction of spherical aberration, 9,19 
(prolateness optimization 20,21).
The aberration neutral (Aberration-FreeTM) profile is 
aspherical-based, 22-24 including a multidynamic aspherical 
transition zone, 23 aberration and focus shift compensation 
due to tissue removal, 17 pseudo-matrix based spot 
positioning, 23 enhanced compensation for the loss of 
efÀ ciency 7,25, and intelligent thermal effect control; 26-28 all 
based on theoretical equations validated with ablation 
models and clinical evaluations.
A 6.7 mm central corrected ablation zone was used in all 
eyes with a variable transition size automatically provided 
by the laser related to the planned refractive correction 
(6.9 mm to 9.2 mm). The ablation was performed using the 
AMARIS 29 excimer laser (SCHWIND eye-tech-solutions, 
Kleinostheim, Germany) which is a Á ying-spot laser using 
ablative spot voxels locally considered through a 
self-constructing algorithm. In addition, there are a 
randomized Á ying-spot ablation pattern and controls for the 
local repetition rates to minimize the thermal load of the 
treatment. 30
Ablations were centred on the corneal vertex (CV) using 
the pupillary offset, i.e., the distance between the pupil 
centre and the normal CV measured by videokeratoscopy 
(Keratron Scout topographer, Optikon 2000 s.p.a., Rome, 
Italy). The measurement was performed under photopic 
conditions of 1500 lux, similar to the conditions under the 
operating microscope. This method was suggested and 
described by de Ortueta and Arba Mosquera 31 and 
comparatively tested by Arbelaez et al. 32 The excimer 
laser allows for modiÀ cation of the ablation centration 
from the pupillary centre with an offset by entering 
either X and Y Cartesian values or R and u polar values in 
a regular treatment. The measurement of the pupillary 
offset was translated into the treatment planning as polar 
coordinates to be manually entered into the excimer laser 
computer.
The AMARIS laser system works at a true repetition rate of 
500 Hz and produces a beam size of 0.54 mm Full-Width-
at-Half-Maximum (FWHM) with a superGaussian ablative 
spot proÀ le. 33,34 High-speed eye-tracking (pupil and limbus 
tracker with cyclotorsional tracking 35) with a 1050-Hz 
acquisition rate is accomplished with a 3-ms latency time. 36
AMARIS technology is treating the astigmatism not by 
superimposing the spherical component with positive or 
negative cylindrical patterns, nor is it treating either 
positive or negative cylindrical patterns depending on the 
sign of the spherical component. Rather, the system 
analytically creates an aspherotoric volume, which is then 
discretised into laser pulses sorted spatially and temporally 
in a pseudo-random fashion. In that way, there is no 
sequentialization of the sphere and astigmatic components 
(nor the other way round), but both components are 
progressively and simultaneously corrected.
Further the AMARIS system has demonstrated its abilities 
for sparing corneal tissue 37 as well as a very even and gently 
ablation preserving preoperative bilateral symmetry. 38
Preoperative Testing
Six-months follow-up was available in 100 of these eyes 
(100 %), and their preoperative data were as follows: mean 
manifest spherical equivalent refraction +3.02 ± 2.06 D 
(range, +0.13 to +5.00 D); mean manifest astigmatism 
magnitude 1.36 ± 1.61 D (range, 0.00 to 5.00 D). In all eyes, 
we measured corneal topography 39 and derived corneal 
wavefront 40,41 analyses (Keratron-Scout, OPTIKON2000, 
Rome, Italy), manifest refraction, and uncorrected and best 
spectacle-corrected Snellen visual acuity 42 (UCVA and BSCVA 
respectively). Results are reported for the measurements 
performed preoperatively and at three and six months after 
surgery.
We acquire, under non pharmacologically dilated pupils, 
non-cycloplegic conditions, and natural dim light conditions 
(to avoid pharmacologically-induced pupil shifts 43-45), 
3 aberrometries (Ocular Wavefront Analyzer, SCHWIND 
eye-tech-solutions GmbH & Co.KG, based on Irx3, Imagine 
Eyes, Orsay, France) and objective refractions for each eye of 
the patient. 46 In order to minimize the potential accommodative 
response of the patients, we ask them to “see-through-the-
target” instead of “looking at the target.” In this way, patients 
do not try to get a sharp image from the +1.5 D fogged target, 
since they were instructed to see-through-the-target. From 
those aberrometries, we calculate the mean, and select the 
most representative one (the aberrometry map with the 
highest similarity to the mean).
We assessed subjective refract ion based upon 
non-pharmacologic and non-cycloplegic conditions, under 
natural photopic illumination. We use the objective 
refraction provided by the aberrometer analyzed for a 
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sub-pupil of 4 mm diameter, as starting refraction for this 
step. This is particularly useful for determining the 
magnitude and orientation of the astigmatism. 47,48 We 
measure manifest refraction, UCVA and BSCVA 42. Further 
rules that we impose for accurately determining the 
manifest subjective refractions among equal levels of BSCVA 
are: taking the measurement with the most positive 
spherical equivalent (unmasking latent hyperopia), if several 
of them are equal in terms of spherical equivalent, we 
choose the measurement with the least amount of 
astigmatism (reducing the risk of postoperative shifts in the 
axis of astigmatism).
Surgical Technique and Postoperative Treatment
For corneal and conjunctival anaesthesia, two drops of 
proparacaine HCl 0.5 % (Aurocaine®, Aurolab, Madurai, India) 
were instilled three times before shifting the patient to the 
Operation Theatre. All flaps were created using a LDV 
femtosecond laser (Ziemer Group) with superior hinges, 
110 mm nominal flap thickness, and 9.0 mm or 9.5 mm 
nominal Á ap diameter. A 9 mm marker was used to ensure 
centration and to be able to objectively measure the amount 
of applanation. Online pachymetry 49 was performed before 
and after lifting flap (stromal bed thickness) with the 
integrated optical coherence pachymeter (Heidelberg 
Engineering, Heidelberg, Germany). After lifting the Á ap, 
ablation was performed preserving Á ap edges, hinge, and 
inner face of the Á ap disk from being ablated. Contact lens 
was applied at the end of surgery (Biomedics 55 evolution, 
Ocular Sciences, Cooper Vision, Hamble, UK) in eyes with 
‘achieved’ Á ap thickness less than 110 microns to avoid Á ap 
displacements, dislocations or striae.
One eye drop Tobradex (Alcon Inc, USA) 3 times a day was 
used for 1 week along with Oasis soft plugs extended 
duration (6404 Glendora CA) and preservative free artiÀ cial 
tear drops during the À rst three months.
Outcome Measures
Safety and effectiveness metrics
EfÀ cacy: We analysed the number of eyes with postoperative 
UCVA in scale from 20/16 to 20/40.
Refractive Outcome: Every dioptric power can be 
represented  by  means  o f  a  po int  in  Euc l idean 
three-dimensional space. The relationship between visual 
acuity and refractive power can be represented by closed 
surfaces of constant visual acuity in symmetric dioptric 
power space. The power of these three component lenses 
may be interpreted as (x,y,z) coordinates of a vector 
representation of the power proÀ le (the U-vector).
The U-vector 50 can be represented as a vector in the 
3-dimensional double angle astigmatism space. 51 The norm 
of this vector correlates to the dioptric blur and to visual 
acuity 52 and can be formulated as:
⎥⎥ U
→
⎥⎥ = √S 2 + S · C + C 2
 2
 (1)
We analysed the mean values of spherical equivalent and 
astigmatism, and the number of treatments with 
postoperative refraction within 0.25, 0.50, 1.00 and 2.00 D, 
as well as, the number of treatments with norm of 
postoperative U-vector within 0.25, 0.50, 1.00 and 2.00 D. 
We assessed the statistical signiÀ cance of the postoperative 
status compared to the preoperative baseline using paired 
Student’s T-tests.
Safety: We analysed differences in BSCVA postoperative 
compared to the preoperative baseline for each eye. We 
assessed the statistical significance of the postoperative 
status compared to the preoperative baseline using paired 
Student’s T-tests.
Predictability: We plotted scattergrams for the achieved 
spherical equivalent and astigmatism corrections versus the 
attempted ones (both at the corneal plane, where the 
ablation procedure occurs). We analysed slope and intercept 
of the correlations. We assessed the statistical signiÀ cance of 
the correlations using Student’s T-tests, the Coefficient 
of Determination (r 2) was used, and the signiÀ cance of the 
correlations has been evaluated considering a metric 
distributed approximately as t with N—2 degrees of freedom 
where N is the size of the sample.
Changes in corneal wavefront aberration
Optical errors centred on the line-of-sight, representing the 
Wavefront Aberration, are described by Zernike polynomials 53 
and coefficients in OSA standard, 54 and analysed for a 
standardised diameter of 6 mm for corneal wavefront.
We analysed mean values and differences, in each of the 
30 HOA terms of the Zernike expansion to the seventh order, 
postoperative compared to the preoperative baseline for 
each eye. We assessed the statistical significance of the 
postoperative status compared to the preoperative baseline 
using paired Student’s T-tests.
Results
Patient Demographics and Adverse events
The mean age at the time of the surgical intervention was 
37 years (from 21 to 59). Forty-six percent of the patients 
were males and 54 % females.
Neither adverse events nor complications were observed 
intra- or postoperatively. In the 6 months follow-up no 
retreatment was performed.
EfÀ cacy and Refractive Outcome
At six-month, UCVA was 20/16 or better in 44 % of the 
treatments (44 eyes), and 20/25 or better in 90 % (90 eyes) 
(Figure 1). The efÀ cacy index scored 0.89. There were no 
statistically significant differences between the 3 and 
6 months follow-ups.
Six-month postoperatively, mean residual spherical 
equivalent was —0.12 ± 0.51D (range, —0.75 to + 1.75D) 
(P < .0001) and mean residual astigmatism 0.50 ± 0.51D 
(range, 0.00 to 1.75D) (P < .0001). Eighty-nine percent eyes 
(89) were within ± 0.50D of attempted spherical equivalent 
correction (Figure 2), with ninety-four percent eyes (94) 
within ± 0.50D of attempted astigmatic correction, 
ninety-seven percent eyes (97) within 1.00D, and ninety-three 
percent eyes (93) within 1.00D of the norm of the residual 
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U-vector (Figure 3). There were no statistically signiÀ cant 
differences between the 3 and 6 months follow-ups.
Safety and Predictability
Regarding safety, 14 % of eyes (14 eyes) gained two lines of 
BSCVA (Figure 4) (P < .01). The safety index scored 1.10. 
There were no statistically signiÀ cant differences between 
the 3 and 6 months follow-ups.
The achieved refractive change, deÀ ned as the vectorial 
difference in the astigmatism space of postoperative and 
preoperative refractions (incorporating spherical equivalent 
and astigmatism) at the corneal plane, was significantly 
correlated with the intended correction (r 2 = .90, P < .0001). 
Regression slope was 1.03, very close to the ideal correction. 
The achieved changes in astigmatism was significantly 
correlated with the intended correction (r 2 = .88, P < .0001). 
The regression slope of 0.91 indicates slight undercorrections. 
There were no statistically signiÀ cant differences between 
the 3 and 6 months follow-ups.
Changes in corneal wavefront aberration
At 6-month follow-up, corneal trefoil aberration increased 
by 0.03 mm (P = .1), corneal coma aberration increased by 
0.04 mm (P = .1), corneal spherical aberration decreased 
by —0.36 mm (P < .0001), and corneal RMS of the HOA 
increased by 0.18 mm (P < .05) (all at 6 mm anaylsis 
diameter).
Discussion
In this study, results were good and promising. We can 
conclude that CAM Aberration-Free Hyperopic treatments 
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Figure 1 Efficacy plot of the UCVA at 3 and 6 months 
postoperative follow-up time.
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Figure 3 Plot of the residual norm of the U-vector within 
range at 3 and 6 months postoperative follow-up time.
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Figure 4 Safety plot of the change in BSCVA at 3 and 6 months 
postoperative follow-up time.
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Figure 2 Refractive outcome plot of the residual refraction 
within range at 3 and 6 months postoperative follow-up time.
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produce safe and predictable ablations on the cornea. 
From post-op VA, we have got 90 % eyes in UCVA 20/25 or 
better and more than 50 % eyes improved their pre-op 
BSCVA, due to the minimum aberrations induction by the 
ORK-CAM aspherical profile. From the refractive power 
change (in terms of achieved correction), we can see that 
both the sphere and cylinder corrections are quite 
accurate, predictable and stable from the first month 
follow-up.
Advanced H-LASIK treatments with AMARIS system yield 
excellent outcomes. Refractions were reduced to subclinical 
values. Mean spherical equivalent was —0.12 ± 0.51D and 
astigmatism 0.50 ± 0.51D. Seventy-four percent of eyes 
were within ± 0.25D of emmetropia. Fifty-two percent of 
eyes gained lines of BSCVA. In Aberration-Free proÀ les the 
induction of aberrations fell well below the clinical 
relevance (< 0.25 D). Only negative spherical aberration was 
significantly induced, but negative spherical aberration 
increases depth of focus, and thus it may help when 
approaching presbyopia.
In these 100 treatments no retreatments were performed 
in the À rst 6 months of follow-up, and after this timeline 
5 retreatments were performed due to undercorrection or 
hyperopic regression. Overall, in our 30-month experience 
with AMARIS, of 348 simple hyperopia or compound 
hyperopic astigmatism treatments performed with AMARIS 
with more than 6 months follow up, only 15 retreatments 
were performed (4 %). Even with today’s technology, 
retreatments are more frequent in hyperopia. The reasons 
for the unexpectedly low retreatment ratio in our hyperopic 
series might be associated to several factors:
On the one hand we do not base our corrections on the 
manifest refraction or on the cycloplegic one. We use the 
objective refraction provided by the aberrometer analyzed 
for a sub-pupil of 4 mm diameter, as starting refraction, 
which is particularly useful for determining the magnitude 
and orientation of the astigmatism, and then we push the 
refraction under test to the the most positive spherical 
equivalent (unmasking latent hyperopia) consistent with the 
highest BSCVA scored by the patient. This does not mean, 
that objective refraction based on wavefront measurement 
is more effective compared to subjective or cicloplegic 
refraction, rather that it is a systematic starting refraction 
for the subjective refraction analysis. Further, if several 
refraction datasets are equal in terms of spherical 
equivalent, we choose the measurement with the least 
amount of astigmatism (reducing the risk of postoperative 
shifts in the axis of astigmatism).
Moreover, we centre our treatments not on the pupil or on 
the 1st Purkinje image, but on an objective assessment of 
the corneal vertex as determined by the videokeratoscopy. 
This offset for the treatment is actually based on the 
vectorial mean of 4 well acquired topographies per treated 
eye. The technological improvements of the AMARIS system 
may also help at that aim, since it incorporates a 
six-dimensional eye-tracking subsystem which tracks not 
only pupil movements, but rolling movements of the eye, as 
well as, torsional movements and movements along the 
propagation axis of the laser.
Finally, we used the objective refraction provided by the 
aberrometer analyzed for a sub-pupil of 4 mm diameter, as 
starting refraction for subjective refraction. This is 
particularly useful for determining the magnitude and 
orientation of the astigmatism. Further, we selected the 
measurement with the most positive spherical equivalent 
(unmasking latent hyperopia).
The results report an improvement of BSCVA of 2 or more 
lines in 14 % of eyes. It is hard to understand why after the 
surgical correction of hyperopia, with less magniÀ cation of 
retinal image, compared to spectacle and without evident 
improvement in ocular aberration, we found an improvement 
in the resolving power of the eye. The minimum aberrations 
induction can justify no reduction of BSCVA, but not such 
improvement.
Although having measured HOA of the whole eye, we 
analyzed only the HOA of the cornea. This has several 
reasons: on the one hand, we used ocular aberrometry 
only to derive refraction, i.e. low order aberration at 
4-mm diameter, so we did not have always large analysis 
diameters available (6-mm or more) for ocular wavefront 
(either pre- or postoperatively); on the other hand we 
were not interested on the magnitude of the aberrations, 
but rather on the change of aberrations.
Papers in which direct comparison of induced corneal and 
ocular wavefront aberrations over the same sample was 
studied, showed that the induction of anterior corneal 
aberrations was always, at least, as high as the induction of 
ocular wavefront aberrations for the entire eye. Marcos et 
al. 55 found that ocular and corneal aberrations increased 
statistically significant after LASIK myopia surgery, by a 
factor of 1.92 (ocular) and 3.72 (corneal), on average. They 
found a good correlation (r = 0.97; P < .0001) between the 
aberrations induced in the entire optical system and those 
induced in the anterior corneal surface. However, anterior 
corneal aberrations increased more than ocular aberrations, 
suggesting also changes in the posterior corneal surface. 
Lee et al. 56 found that after laser refractive surgery, anterior 
corneal aberration and ocular aberration increased equally 
and showed statistically signiÀ cant correlations. They found 
no statistically significant differences of internal optics 
aberration values in coma, spherical aberration, and RMS 
for HOA. Arbelaez et al. 16 found that comparing corneal and 
ocular aberrations, the amount of induced aberrations was 
very similar for spherical aberration and coma. For the RMS 
for HOA corneal induced aberrations were moderately 
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Figure 5 Plot of the change in corneal high order aberrations 
at 6 months postoperative follow-up time.
204 M.C. Arbelaez et al
higher, despite not statistically significant, than ocular 
induced aberrations. Arba-Mosquera and de Ortueta 57 found 
that induced corneal and ocular spherical aberrations were 
correlated in a statistically signiÀ cant manner, with ocular 
spherical aberration being induced at a rate of half of the 
induced corneal spherical aberration in patients preoperative 
and in the same patients after LASIK for myopic 
astigmatism.
Hyperopic Aberration-Free Treatments with the SCHWIND 
AMARIS are safe and very predictable. Results were achieved 
without applying additional nomograms. 6-month follow-up 
time shows the good performance of the system. To evaluate 
the long-term stability further follow up is necessary. 
However, de Ortueta et al. 58 determined good refractive 
and topographic stability after H-LASIK already from the 
3 month of follow-up with little to no regression occurring 
up to 36 months.
De Ortueta 12 found after H-LASIK with the ESIRIS system a 
good predictability, with 92 % of the eyes (61) having a 
postoperative refraction within ± 0.50 D of the attempted 
correction. Moreover, as expected, the achieved refractive 
change was signiÀ cantly correlated with intended refractive 
correction (r 2 = 0.91), and was very close to the ideal 
correction. These values are similar to the ones in this study 
for 1-year follow-up (95 % within 0.50 D).
The conventionally accepted limits for H-LASIK (about 5D 
of spherical equivalent) are lower than the ones accepted 
for myopic LASIK (up to about 10D if the residual stromal 
bed is thicker than 250-300 mm). One of the causes is that 
the induction of aberrations per achieved diopter is higher 
in hyperopic treatments. 9 The centration of refractive 
surgery remains also controversial. The offset between the 
corneal vertex and pupil centre is higher in hyperopic eyes, 
with a nasal fixation in most of the cases. This is also a 
problem to take into account. 59 Hyperopic eyes are usually 
short in axial length, showing higher values for the angles 
alpha, kappa, and lambda. This also causes an offset 
between the corneal vertex and the pupil centre of higher 
magnitude than in myopic eyes, making it difÀ cult to decide 
where to centre the refractive procedure.
It is possible that the ‘improved’ results are simply due to 
treatment centration, rather than to the new AMARIS 
technology. New ablation patterns, which minimize the 
induction of aberrations, will allow us to perform H-LASIK 
more predictably and safely and may allow us in the 
future to treat higher hyperopia. At this aim, the limits 
to the steepness of the central cornea with regards to 
quality of vision and tear À lm stability shall be carefully 
considered.
Reducing the induction of aberrations after H-LASIK will 
possibly allow us to treat higher hyperopia, however further 
studies are necessary to conÀ rm this hypothesis.
ConÁ ict of interests
Authors Arbelaez and Vidal have no proprietary interest in 
the materials presented herein.
Arbelaez receives travel expenses from SCHWIND 
eye-tech-solutions.
Arba-Mosquera is employee of SCHWIND eye-tech-
solutions.
References
 1. Llorente L, Barbero S, Merayo J, Marcos S. Changes in corneal 
and total aberrations induced by LASIK surgery for hyperopia. J 
Refract Surg. 2004;20:203-216.
 2. Chen CC, Izadshenas A, Asghar Rana MA, Azar DT. Corneal 
asphericity after hyperopic laser in situ keratomileusis. J 
Cataract Refract Surg. 2002;28:1539-1545.
 3. Jiménez JR, Anera RG, del Barco LJ, Hita E. Predicting changes 
in corneal asphericity after hyperopic LASIK. J Cataract Refract 
Surg. 2003;29:1468.
 4. Mrochen M, Seiler T. Influence of corneal curvature on 
calculation of ablation patterns used in photorefractive laser 
surgery. J Refract Surg. 2001;17:584-587.
 5. Jiménez JR, Anera RG, Jiménez del Barco L, Hita E. Effect on 
laser-ablation algorithms of reÁ ection losses and nonnormal 
incidence on the anterior cornea. Applied Physics Letters. 
2002;81;8:1521-1523.
 6. Dorronsoro C, Cano D, Merayo-Lloves J, Marcos S. Experiments 
on PMMA models to predict the impact of corneal refractive 
surgery on corneal shape. Opt Express. 2006;14:6142-6156.
 7. Arba Mosquera S, de Ortueta D. Geometrical analysis of the loss 
of ablation efÀ ciency at non-normal incidence. Opt Express. 
2008;16:3877-3895.
 8. Dupps WJ, Roberts C. Effect of acute biomechanical changes on 
corneal curvature after photokeratectomy. J Cataract Refract 
Surg. 2002;18:S589-592.
 9. Yoon G, MacRae S, Williams DR, Cox IG. Causes of spherical 
aberration induced by laser refractive surgery. J Cataract 
Refract Surg. 2005;31:127-135.
10. Wang L, Koch D. Anterior corneal optical aberrations induced 
by laser in situ keratomileusis for hyperopia J Cataract Refract 
Surg. 2003;29:1702–1708.
11. Albarrán-Diego C, Muñoz G, Montés-Micó R, Rodriguez A, Alió 
JL. Corneal Aberration Changes After Hyperopic LASIK: A 
Comparison Between the VISX Star S2 and the Asclepion-Meditec 
MEL 70 G Scan Excimer Lasers. J Refract Surg. 2006;22:34-42.
12. de Ortueta D, Arba-Mosquera S, Baatz H. Topographic changes 
after hyperopic LASIK with the SCHWIND ESIRIS laser platform. 
J Refract Surg. 2008;24:137-144.
13. O‘Brart DP, Mellington F, Jones S, Marshall J. Laser epithelial 
keratomileusis for the correction of hyperopia using a 7.0-mm 
optical zone with the Schwind ESIRIS laser. J Refract Surg. 2007; 
23:343-354.
14. de Ortueta D, Arba Mosquera S, Baatz H. Aberration-neutral 
ablation pattern in hyperopic LASIK with the ESIRIS laser 
platform. J Refract Surg. 2009;25:175-184.
15. Arba-Mosquera S, Hollerbach T. Ablation resolution in laser 
corneal refractive surgery: the dual Á uence concept of the 
AMARIS Platform. Advances in Optical Technologies, vol. 2010, 
Article ID 538541, 13 pages, 2010. doi:10.1155/2010/538541
16. Arbelaez MC, Vidal C, Al Jabri B, Arba Mosquera S. LASIK for 
Myopia With Aspheric “Aberration Neutral” Ablations Using the 
ESIRIS Laser System. J Refract Surg. 2009;25:991-999.
17. Arba Mosquera S, de Ortueta D. Analysis of optimized proÀ les 
for ‘aberration-free’ refractive surgery. Ophthalmic Physiol 
Opt. 2009;29:535-548.
18. Munnerlyn CR, Koons SJ, Marshall J. Photorefractive 
keratectomy: a technique for laser refractive surgery. J Cataract 
Refract Surg. 1988;14:46–52.
19. Hersh PS, Fry K, Blaker JW. Spherical aberration after laser in 
situ keratomileusis and photorefractive keratectomy. Clinical 
results and theoretical models of etiology. J Cataract Refract 
Surg. 2003;29:2096-2104.
20. Gatinel D, Malet J, Hoang-Xuan T, Azar DT. Analysis of 
customized corneal ablations: theoretical limitations 
of increasing negative asphericity. Invest Ophthalmol Vis Sci. 
2002;43:941-948.
Six-month clinical outcomes after hyperopic correction with the SCHWIND AMARIS Total-Tech laser 205
21. Calossi A. Corneal asphericity and spherical aberration. J 
Refract Surg. 2007;23:505-514.
22. de Ortueta D, Arba Mosquera S. Mathematical properties of 
asphericity: a method to calculate with asphericities. J Refract 
Surg. 2008;24:119-121.
23. de Ortueta D, Arba Mosquera S, Baatz H. Comparison of 
Standard and Aberration neutral ProÀ les for Myopic LASIK With 
the SCHWIND ESIRIS. J Refract Surg. 2009;25:339-349.
24. Arba Mosquera S, Merayo-Lloves J, de Ortueta D. Asphericity 
analysis using corneal wavefront and topographic meridional 
À ts. J Biomed Opt. 2010; 15: 028003.
25. de Ortueta D, Arba Mosquera S, Häcker C. Theoretical 
considerations on the hyperopic shift effect observed when 
treating negative cylinder in laser refractive surgery. Journal of 
Emmetropia 2010;1:23-28.
26. Arba Mosquera S, Shraiki M. Analysis of the PMMA and cornea 
temperature rise during excimer laser ablation. J Modern Opt. 
2010;57:400-407.
27. Brunsmann U, Sauer U, Dressler K, Triefenbach N, Arba 
Mosquera S. Minimisation of the thermal load of the ablation in 
high-speed laser corneal refractive surgery: the ‘intelligent 
thermal effect control’ of the AMARIS platform. J Modern Opt. 
2010;57:466-479.
28. Brunsmann U, Sauer U, Arba-Mosquera S, Magnago T, 
Triefenbach N. Evaluation of thermal load during laser corneal 
refractive surgery using infrared thermography. Infrared Physics 
& Technology. 2010;53:342–347.
29. Arbelaez MC, Vidal C, Arba Mosquera S. Excimer laser correction 
of moderate to high astigmatism with a non-wavefront-guided 
aberration-free ablation proÀ le: Six-month results. J Cataract 
Refract Surg. 2009;35:1789-1798.
30. Bende T, Seiler T, Wollensak J, Corneal Thermal Gradients, 
Graef Arch Ophthalm. 1988;226:277-280.
31. de Ortueta D, Arba Mosquera S. Centration during hyperopic 
LASIK using the coaxial light reÁ ex. J Refract Surg. 2007;23:11.
32. Arbelaez MC, Vidal C, Arba Mosquera S. Clinical outcomes of 
corneal vertex versus central pupil references with 
aberration-free strategies and LASIK. Invest Ophthalmol Vis Sci. 
2008;49:5287-5294.
33. Huang D, Arif M. Spot size and quality of scanning laser 
correction of higher-order wavefront aberrations. J Cataract 
Refract Surg. 2002;28:407-416.
34. Guirao A,Williams D, MacRae S. Effect of beam size on the 
Expected benefit of customized laser refractive surgery. J 
Refract Surg. 2003;19:15-23.
35. Arba Mosquera S, Merayo-Lloves J, de Ortueta D. Clinical 
effects of pure cyclotorsional errors during refractive surgery. 
Invest Ophthalmol Vis Sci. 2008;49:4828-4836.
36. Bueeler M, Mrochen M. Simulation of Eye-tracker Latency, Spot 
Size, and Ablation Pulse Depth on the Correction of Higher 
Order Wavefront Aberrations With Scanning Spot Laser Systems. 
J Refract Surg. 2005;21:28-36.
37. Arba Mosquera S, de Ortueta D, Merayo-Lloves J. Tissue-Saving 
Zernike Terms Selection in Customized Treatments for 
Refractive Surgery. J Optom. 2009;2:182-196.
38. Arbelaez MC, Vidal C, Arba-Mosquera S. Bilateral Symmetry 
before and Six Months after Aberration-Free™ Correction with 
the SCHWIND AMARIS TotalTech Laser: Clinical Outcomes. J 
Optom. 2010;3:20-28.
39. Mattioli R, Tripoli NK. Corneal geometry reconstruction with 
the Keratron videokeratographer. Optom Vis Sci. 1997;74: 
881-894.
40. Salmon TO. Corneal contribution to the Wavefront aberration 
of the eye. PhD Dissertation. 1999: 70.
41. Arbelaez MC, Vidal C, Arba Mosquera S. Clinical outcomes of 
corneal wavefront customized ablation strategies with SCHWIND 
CAM in LASIK treatments. Ophthalmic Physiol Opt. 2009;29: 
487-496.
42. Snellen H. Letterproeven tot Bepaling der Gezichtsscherpte. 
Utrecht: Weyers; 1862.
43. Tuan KA, Somani S, Chernyak DA. Changes in wavefront 
aberration with pharmaceutical dilating agents. J Refract Surg. 
2005;21:S530-534.
44. Yang Y, Wu F. Technical note: Comparison of the wavefront 
aberrations between natural and pharmacological pupil 
dilations. Ophthalmic Physiol Opt. 2007;27:220-223.
45. Erdem U, Muftuoglu O, Gundogan FC, Sobaci G, Bayer A. Pupil 
center shift relative to the coaxially sighted corneal light reÁ ex 
under natural and pharmacologically dilated conditions. J 
Refract Surg. 2008;24:530-538.
46. Arbelaez MC, Vidal C, Arba Mosquera S. Clinical Outcomes of 
LASIK for Myopia Using the SCHWIND Platform With Ocular 
Wavefront Customized Ablation. J Refract Surg. 2009;25: 
1083-1090.
47. Salmon TO, West RW, Gasser W, Kenmore T. Measurement of 
refractive errors in young myopes using the COAS 
Shack-Hartmann aberrometer. Optom Vis Sci. 2003;80:6-14.
48. Marsack JD, Thibos LN, Applegate RA. Metrics of optical quality 
derived from wave aberrations predict visual performance. J 
Vis. 2004;4:322-328.
49. Arbelaez MC, Vidal C, Arba Mosquera S. Central Ablation Depth 
and Postoperative Refraction in Excimer Laser Myopic 
Correction Measured With Ultrasound, ScheimpÁ ug, and Optical 
Coherence Pachymetry. J Refract Surg. 2009;25:699-708.
50. Thibos LN, Wheeler W, Horne, D. A vector method for the 
analysis of astigmatic refractive errors. Vision Science and Its 
Applications, Washington: Optical Society of America; 1994. 
p. 14-17.
51. Harris WF. Representation of dioptric power in Euclidean space. 
Ophthal Physio Opt.1991;11:130-136.
52. Rubin A, Harris WF. Closed surfaces of constant visual acuity in 
symmetric dioptric power space. Optom Vis Sci. 2001;78: 
744-753.
53. Zernike F. Diffraction theory of the knife-edge test and its 
improved form, the phase-contrast method. Monthly Notices of 
the Royal Astronomical Society. 1934;94:377-384.
54. Thibos LN, Applegate RA, Schwiegerling JT, Webb R, VSIA 
Standards Taskforce Members. Standards for Reporting the 
Optical Aberrations of Eyes. J Refract Surg. 2002;18:S652-660.
55. Marcos S, Barbero S, Llorente L, Merayo-Lloves J. Optical 
response to LASIK surgery for myopia from total and corneal 
aberration measurements. Invest Ophthalmol Vis Sci. 
2001;42:3349-3356.
56. Lee JM, Lee DJ, Jung WJ, Park WC. Comparison between 
anterior corneal aberration and ocular aberration in laser 
refractive surgery. Korean J Ophthalmol. 2008;22:164-168.
57. Arba Mosquera S, de Ortueta D. Correlation among ocular 
spherical aberration, corneal spherical aberration, and corneal 
asphericity before and after LASIK for myopic astigmatism with 
the SCHWIND Amaris Platform at JRS. J Refractive Sourgery. 
2010; Online Advanced Release. doi:10.3928/1081597X-201010
01-01.
58. de Ortueta D, Arba Mosquera S. Topographic Stability After 
Hyperopic LASIK. J Refract Surg. 2010;26:547-554.
59. Boxer Wachler BS, Korn TS, Chandra NS, Michel FK. Decentration 
of the optical zone: Centering on the pupil versus the coaxially 
sighted corneal light reÁ ex in LASIK for hyperopia. J Refract 
Surg. 2003;19:464-465.
